- Country: Costa Rica
- Summary: Octreotide 20 Mg (As Octreotide Acetate). Code: 1-10-32-4375 and Octreotide 30 Mg (As Octreotide Acetate). Code: 1-10-32-4385
- CRT Ref No: 130453245
- Deadline: 03 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CRC 1315334498
- Notice Type: Tender
- Document Ref. No.: 2025XE-000178-0001101142
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Octreotide 20 mg (as octreotide acetate). Code: 1-10-32-4375 and Octreotide 30 mg (as octreotide acetate). Code: 1-10-32-4385
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINOctreotide 20 Mg (As Octreotide Acetate). Code: 1-10-32-4375 and Octreotide 30 Mg (As Octreotide Acetate). Code: 1-10-32-4385 - Costarica Tender
The COSTA RICAN SOCIAL SECURITY FUND, a Government sector organization in Costa Rica, has announced a new tender for Octreotide 20 Mg (As Octreotide Acetate). Code: 1-10-32-4375 and Octreotide 30 Mg (As Octreotide Acetate). Code: 1-10-32-4385. This tender is published on CostaricaTenders under CRT Ref No: 130453245 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-03.
The estimated tender value is CRC 1315334498, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
